InvestorsHub Logo

mc67

05/06/21 9:23 AM

#39343 RE: mc67 #39341

also Mav This is what I got today:

Thank you for your recent e-mail. You asked about the dispute between Relief and NeuroRx. What we can say is that Relief is actively and constructively striving to find an amicable solution to resolve the dispute. Despite the dispute, we believe that both parties remain committed and continue to work to bring RLF-100 (aviptadil) forward.



Kind regards,

Relief Therapeutics

djhfsu

05/06/21 9:30 AM

#39346 RE: mc67 #39341

Thanks for sharing mc67. I read this on the Yahoo board earlier this morning. I like the "Relief is actively and constructively striving to find an amicable solution to the resolve the dispute". That definitely tells me there is a communication breakdown and also some issue with patents and/or allocation of profits.

I believe they will work it out under a win-win. It could simply be Neuro is overwhelmed with all the workload and they haven't provided all the necessary documents for reimburse. However, my gut tells me this is more about profit sharing arrangement. If correct, this is a positive because Neuro feels like they have something special in their formulation.

Time will tell. Good luck to all...even the negative rehashers.

Dave